Lipoprotein lipase activators

DBCAT005271Pharmacologic class

Compounds that increase the enzymatic activity of LIPOPROTEIN LIPASE. Lipoprotein lipase activators have a potential role in the treatment of OBESITY by increasing LIPID METABOLISM. A DrugBank category of 1 drug.

Drugs: Ibrolipim

What you can answer from here — as of January 29, 2021

1DrugEach linked to its full drug card

Listed above

1Drug targetEvery drug–target pair in the class, with bond type

Which targets do Lipoprotein lipase activators share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account